Wedgewood Investors’s Celgene Corp CELG Stock Holding History

Wedgewood Investors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,470	Closed	-$245K	–	91
2019 Q3	$245K	Hold	2,470	–	–	0.37%	75
2019 Q2	$228K	Sell	2,470 -30	-1%	-$2.85K	0.33%	79
2019 Q1	$236K	Buy	+2,500	New	+$219K	0.37%	75
2018 Q4	–	Sell	-2,500	Closed	-$224K	–	85
2018 Q3	$224K	Buy	+2,500	New	+$221K	0.35%	81
2018 Q2	–	Sell	-2,500	Closed	-$223K	–	86
2018 Q1	$223K	Hold	2,500	–	–	0.19%	107
2017 Q4	$261K	Hold	2,500	–	–	0.21%	98
2017 Q3	$365K	Sell	2,500 -40	-2%	-$5.45K	0.31%	74
2017 Q2	$330K	Hold	2,540	–	–	0.28%	82
2017 Q1	$316K	Hold	2,540	–	–	0.28%	83
2016 Q4	$294K	Hold	2,540	–	–	0.27%	84
2016 Q3	$266K	Hold	2,540	–	–	0.25%	89
2016 Q2	$251K	Hold	2,540	–	–	0.24%	92
2016 Q1	$254K	Hold	2,540	–	–	0.26%	85
2015 Q4	$304K	Hold	2,540	–	–	0.31%	77
2015 Q3	$275K	Hold	2,540	–	–	0.28%	83
2015 Q2	$294K	Hold	2,540	–	–	0.28%	85
2015 Q1	$293K	Buy	+2,540	New	+$304K	0.28%	89

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Wedgewood Investors's CELG Position: Q4 2019 in Review

Wedgewood Investors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,470 shares — an estimated $245K sold.

Wedgewood Investors first reported a position in CELG in Q1 2015 and held it in 17 quarters. The position peaked at $365K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Wedgewood Investors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Wedgewood Investors sold 2,470 Celgene Corp shares in Q4 2019, an estimated $245K.
Wedgewood Investors first reported a position in Celgene Corp in Q1 2015 and held it in 17 quarters.
Wedgewood Investors's Celgene Corp position peaked at $365K in Q3 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wedgewood Investors's 13F filing for Q4 2019, filed 6 Feb 2020.